MedPath

NITRO-BID

NITRO-BID (Nitroglycerin Ointment USP, 2%)

Approved
Approval ID

e464e9bb-48e8-4b9f-9fff-e220cfbac0c5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 25, 2021

Manufacturers
FDA

Savage Laboratories a division of Fougera Pharmaceuticals Inc.

DUNS: 043838424

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nitroglycerin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0281-0326
Application NumberANDA087355
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nitroglycerin
Product Specifications
Route of AdministrationTOPICAL
Effective DateAugust 25, 2021
FDA Product Classification

INGREDIENTS (4)

nitroglycerinActive
Quantity: 20 mg in 1 g
Code: G59M7S0WS3
Classification: ACTIB
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
petrolatumInactive
Code: 4T6H12BN9U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NITRO-BID - FDA Drug Approval Details